Exploring the sequence features determining amyloidosis in human antibody light chains
Abstract The light chain (AL) amyloidosis is caused by the aggregation of light chain of antibodies into amyloid fibrils. There are plenty of computational resources available for the prediction of short aggregation-prone regions within proteins. However, it is still a challenging task to predict th...
Main Authors: | Puneet Rawat, R. Prabakaran, Sandeep Kumar, M. Michael Gromiha |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-93019-9 |
Similar Items
-
Exploring antibody repurposing for COVID-19: beyond presumed roles of therapeutic antibodies
by: Puneet Rawat, et al.
Published: (2021-05-01) -
LIGHT CHAIN AMYLOIDOSIS
by: Paolo Milani, et al.
Published: (2018-03-01) -
Light-Chain Cardiac Amyloidosis
by: Gonzalo Barge-Caballero, MD, et al.
Published: (2019-10-01) -
Global epidemiology of amyloid light-chain amyloidosis
by: Nishant Kumar, et al.
Published: (2022-07-01) -
The clinical features and outcomes of systemic light chain amyloidosis with hepatic involvement
by: Liang Zhao, et al.
Published: (2022-12-01)